Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kimura, H; Sasaki, S; Inukai, S; Takeishi, M
   Biosynthesis of poly (3-hydroxyalkanoate)s with terminal alkene groups in the side chains by Chromobacterium sp. (Nov, pg 1189, 1999)
   CHEMISTRY LETTERS
   
   H. Kimura et al., "Biosynthesis of poly (3-hydroxyalkanoate)s with terminal alkene groups in the side chains by Chromobacterium sp. (Nov, pg 1189, 1999)", CHEM LETT, (12), 1999, pp. 1347-1347
2. Kimura, H; Sasaki, S; Inukai, S; Takeishi, M
   Biosynthesis of poly(3-hydroxyalkanoate)s with terminal alkene groups in the side chains by Chromobacterium sp.
   CHEMISTRY LETTERS
   
   H. Kimura et al., "Biosynthesis of poly(3-hydroxyalkanoate)s with terminal alkene groups in the side chains by Chromobacterium sp.", CHEM LETT, (11), 1999, pp. 1189-1190
3. HOTTA N; NAKAMURA J; SAKAKIBARA F; HAMADA Y; HARA T; MORI K; NAKASHIMA E; SASAKI H; KASAMA N; INUKAI S; KOH N
   ELECTRORETINOGRAM IN SUCROSE-FED DIABETIC RATS TREATED WITH AN ALDOSEREDUCTASE INHIBITOR OR AN ANTICOAGULANT
   American journal of physiology: endocrinology and metabolism
   
   N. Hotta et al., "ELECTRORETINOGRAM IN SUCROSE-FED DIABETIC RATS TREATED WITH AN ALDOSEREDUCTASE INHIBITOR OR AN ANTICOAGULANT", American journal of physiology: endocrinology and metabolism, 36(5), 1997, pp. 965-971
4. HOTTA N; KAKUTA H; FUKASAWA H; KOH N; SAKAKIBARA F; NAKAMURA J; HAMADA Y; WAKAO T; HARA T; MORI K; NARUSE K; NAKASHIMA E; INUKAI S; SAKAMOTO N
   EFFECT OF A POTENT NEW ALDOSE REDUCTASE INHIBITOR, (5-(3-THIENYL)TETRAZOL-1-YL)ACETIC ACID (TAT), ON DIABETIC NEUROPATHY IN RATS
   Diabetes research and clinical practice
   
   N. Hotta et al., "EFFECT OF A POTENT NEW ALDOSE REDUCTASE INHIBITOR, (5-(3-THIENYL)TETRAZOL-1-YL)ACETIC ACID (TAT), ON DIABETIC NEUROPATHY IN RATS", Diabetes research and clinical practice, 27(2), 1995, pp. 107-117
5. MATSUMOTO K; INUKAI S; ISAKA T; ARUGA N; NAKAMURA S; NAGASAWA T; NAITO J
   CELL COUNTS IN PERIPHERAL-BLOOD AND BONE-MARROW OF MALE C.B-17 SCID SCID MICE/
   Laboratory animals
   
   K. Matsumoto et al., "CELL COUNTS IN PERIPHERAL-BLOOD AND BONE-MARROW OF MALE C.B-17 SCID SCID MICE/", Laboratory animals, 29(2), 1995, pp. 218-222
6. HARA T; NAKAMURA J; KOH N; SAKAKIBARA F; HAMADA Y; SASAKI H; NARUSE K; NAKASHIMA E; TAKEUCHI N; INUKAI S; HOTTA N
   AN ALDOSE REDUCTASE INHIBITOR, TAT, REDUCES ADP-INDUCED PLATELET HYPERAGGREGATION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS WITH NEUROPATHY
   The Journal of laboratory and clinical medicine
   
   T. Hara et al., "AN ALDOSE REDUCTASE INHIBITOR, TAT, REDUCES ADP-INDUCED PLATELET HYPERAGGREGATION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS WITH NEUROPATHY", The Journal of laboratory and clinical medicine, 126(6), 1995, pp. 541-547
7. HOTTA N; KOH N; SAKAKIBARA F; NAKAMURA J; HAMADA Y; HARA T; TAKEUCHI N; INUKAI S; KASAMA N; FUKASAWA H; KAKUTA H
   AN ALDOSE REDUCTASE INHIBITOR, TAT, PREVENTS ELECTRORETINOGRAPHIC ABNORMALITIES AND ADP-INDUCED HYPERAGGREGABILITY IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
   European journal of clinical investigation
   
   N. Hotta et al., "AN ALDOSE REDUCTASE INHIBITOR, TAT, PREVENTS ELECTRORETINOGRAPHIC ABNORMALITIES AND ADP-INDUCED HYPERAGGREGABILITY IN STREPTOZOTOCIN-INDUCED DIABETIC RATS", European journal of clinical investigation, 25(12), 1995, pp. 948-954